Cargando…
Efficacy of cyclin-dependent kinase 4/6 inhibitors in patients with metastatic hormone positive breast cancer: a single institutional study from India
PURPOSE: Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors have shown marked benefit in the treatment of hormone positive metastatic breast cancer (HR+ MBC). There are limited real-world studies with palbociclib and ribociclib. Here we report our experience with CDK4/6 inhibitors in these groups of pa...
Autores principales: | Ganguly, Sandip, Mukherjee, Navonil, Mandal, Sayan, Roy, Somnath, Agarwal, Sanjit, Biswas, Bivas, Ghosh, Joydeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666281/ https://www.ncbi.nlm.nih.gov/pubmed/36405937 http://dx.doi.org/10.3332/ecancer.2022.1450 |
Ejemplares similares
-
Not so ‘rare’—an example of malignant melanoma in India: report from a tertiary cancer centre
por: Biswas, Bivas, et al.
Publicado: (2021) -
PDL1 expression and its correlation with outcomes in non-metastatic triple-negative breast cancer (TNBC)
por: Ghosh, Joydeep, et al.
Publicado: (2021) -
Outcome of COVID-19 in Solid Organ Malignancies: Experience From a Tertiary Cancer Center in Eastern India
por: Roy, Somnath, et al.
Publicado: (2021) -
First-line Rucaparib Plus Bevacizumab Maintenance Completed One-Year in Germline BRCA1-Mutated Advanced Ovarian Cancer
por: Roy, Somnath, et al.
Publicado: (2022) -
Metastatic Gastric cancer: Real world scenario from a developing country
por: Ganguly, Sandip, et al.
Publicado: (2018)